Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Letter

<< Previous

Bullboard Posts

Next >>

Comment by qwerty22on Jan 04, 2023 3:05pm

114 Views

Post# 35203392

RE:RE:RE:Letter

I don't mind the timing of this announcement. If they needed to wait until now then so be it, it was more a general plea to be more open.

palinc2000 wrote: There were those holding the stock in expectations that Th 1902 woukd be an instant success ....When the pause was announced they ran for the exit .....I dont think the letter woud have changed much then......I agree that comunication can be improved ...if there are FACTS

qwerty22 wrote:
Paul the SP is up because you talked. Learn.

Scioto wrote: Small step. But important. Need to build-up relationship brick by brick. Communication is critical.